Intra-Cellular Therapies, Inc.

CIK 1567514 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Intra-Cellular Therapies, Inc..

Recent SEC filings

FiledFormAccession number
Jun 5, 2025SCHEDULE 13G/A0000019617-25-000501
Apr 14, 202515-12G0001193125-25-079742
Apr 9, 2025EFFECT9999999995-25-001048
Apr 2, 2025S-8 POS0001193125-25-071368
Apr 2, 2025S-8 POS0001193125-25-071365
Apr 2, 202540000950170-25-049593
Apr 2, 20258-K0001193125-25-071325
Apr 2, 2025S-8 POS0001193125-25-071359
Apr 2, 202540000950170-25-049592
Apr 2, 202540000950170-25-049595
Apr 2, 2025POS AM0001193125-25-071328
Apr 2, 202525-NSE0001354457-25-000272
Apr 2, 2025S-8 POS0001193125-25-071334
Apr 2, 202540000950170-25-049596
Apr 2, 2025POSASR0001193125-25-071392
Apr 2, 202540000950170-25-049646
Apr 2, 2025S-8 POS0001193125-25-071353
Apr 2, 202540000950170-25-049648
Apr 2, 2025S-8 POS0001193125-25-071360
Apr 2, 202540000950170-25-049830
Apr 2, 202540000950170-25-049627
Apr 2, 202540000950170-25-049636
Mar 31, 202540000950170-25-047937
Mar 27, 20258-K0001193125-25-065507
Mar 20, 202510-K/A0001628280-25-014154